Abiopharma

New Form 8-K - Revolution Medicines, Inc. Filed: 2025-06-24 AccNo: 0001193125-25-145242 Size: 256 KB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits